|
|
Other links at Articles > HIV/AIDS |
| 1. |
Abbott to Settle Lawsuit Over HIV Drug Pricing
|
|
|
Abbott Laboratories has agreed to pay between $10 million and $27.5 million to settle a lawsuit contending it improperly raised the price of its HIV drug Norvir by 400 percent. Reuters Health Information
|
| 3. |
Integrase Inhibitor Raises Questions About HIV Kinetics
|
|
|
Raltegravir, a novel integrase inhibitor, enhances both phases of HIV decay, researchers report. This "challenges the current understanding of HIV-1 turnover and compartmentalization," they note in the November 12th issue of AIDS. Reuters Health Information
|
| 4. |
Attention to Noninfectious Perimortal Conditions in HIV Patients Needed
|
|
|
Since the introduction of highly active antiretroviral therapy (HAART) in the United States, there has been a downward trend in many infectious perimortal diseases but an upward trend in noninfectious perimortal conditions, according to results of a study. Reuters Health Information
|
|
|
